Rosetta Genomics Ltd.
(Other OTC/NBB : ROSG)

( )
ROSG PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. -4.97%136.250.0%$893.93m
AMGNAmgen, Inc. 1.12%247.501.5%$828.95m
GILDGilead Sciences, Inc. 0.90%63.841.0%$542.01m
VRTXVertex Pharmaceuticals, Inc. 1.23%258.591.9%$461.95m
REGNRegeneron Pharmaceuticals, Inc. 0.61%661.142.6%$422.10m
ILMNIllumina, Inc. 1.14%243.493.3%$313.80m
NVAXNovavax, Inc. -8.57%53.4275.7%$307.51m
BIIBBiogen, Inc. 3.40%199.651.8%$240.05m
BNTXBioNTech SE -2.90%163.000.0%$226.41m
SNSSSunesis Pharmaceuticals, Inc. 1.93%2.110.7%$147.50m
EXASEXACT Sciences Corp. -1.54%53.1717.7%$147.09m
TXG10X Genomics, Inc. 0.58%50.160.0%$101.29m
TECHBio-Techne Corp. -0.03%366.354.5%$100.80m
NKTXNkarta, Inc. -1.78%12.670.0%$99.26m
BMRNBioMarin Pharmaceutical, Inc. 0.56%79.724.2%$98.40m

Company Profile

Rosetta Genomics Ltd. provides therapeutic, diagnostic product development and medical research services. The company develops and commercializes new diagnostic tests based on various genomics markers, including DNA, microRNA and protein biomarkers and using various technologies, including, qPCR, microarrays, next generation sequencing and fluorescence in situ hybridization. It offers proprietary microRNA technologies, such as Rosetta Cancer Origin, mi-KIDNEY, and RosettaGX Reveal Test. The company was founded by Isaac Bentwich on March 9, 2000 and is headquartered in Rehovot, Israel.